G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35969743 | O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling | Chen L | 2022 Aug 15 |
|
| 35871308 | Ultrasensitive assay of O‐GlcNAc transferase using capillary electrophoresis‐laser induced fluorescence | Liu J | 2022 Aug 15 |
|
| 35906001 | Molecular and Structural Basis of Receptor Binding and Signaling of a Fish Type I IFN with Three Disulfide Bonds | Chen J | 2022 Aug 15 |
|
| 35960796 | A naturally arising broad and potent CD4-binding site antibody with low somatic mutation | Barnes CO | 2022 Aug 12 |
|
| 35907402 | Cryo-EM structures of human fucosidase FucA1 reveal insight into substrate recognition and catalysis | Armstrong Z | 2022 Aug 10 |
|
| 36048150 | Native glycosylation and binding of the antidepressant paroxetine in a low-resolution crystal structure of human myeloperoxidase | Krawczyk L | 2022 Aug 09 |
|
| 35939703 | Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH | Garcia-Moro E | 2022 Aug 08 |
|
| 35939295 | Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor | Iijima D | 2022 Aug 08 |
|
| 35940204 | Hormone- and antibody-mediated activation of the thyrotropin receptor | Duan J | 2022 Aug 08 |
|
| 35940205 | Autoantibody mimicry of hormone action at the thyrotropin receptor | Faust B | 2022 Aug 08 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025